ELMD · Electromed, Inc.

Represents shares forfeited to satisfy tax withholding obligations in connection with vesting of previously awarded shares of restricted stock.

Reflects the weighted average price of 1,671 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $36.62 to $37.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects the weighted average price of 7,003 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $35.61 to $36.60 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects the weighted average price of 1,026 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $37.69 to $38.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Options scheduled to vest and become exercisable in three equal annual installments on each of the first business days of September 2025, 2026 and 2027.

Reflects the weighted average price of 11,620 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $36.04 to $37.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Scheduled to vest and become exercisable with respect to remaining shares on June 30, 2026.

Scheduled to vest and become exercisable with respect to remaining shares on June 30, 2026.

Reflects the weighted average price of 181 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $37.055 to $37.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects the weighted average price of 8,150 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $33.86 to $34.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Fully vested.

Reflects the weighted average price of 9,256 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $35.87 to $36.74 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects the weighted average price of 19,032 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on May 15, 2026 with sale prices ranging from $34.872 to $35.86 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

Reflects the weighted average price of 3,153 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 11, 2025 with sale prices ranging from $24.39 to $24.46 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 39,378 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $23.52 to $24.51 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 6,576 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $25.515 to $26.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 16,203 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $24.52 to $25.51 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 404 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $26.525 to $26.635 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Restricted stock scheduled to vest in three equal annual installments on each of the first business days of September 2026, 2027 and 2028.

Represents shares forfeit to satisfy tax withholding obligations in connection with vesting of previously awarded shares of restricted stock.

Represents shares forfeit to satisfy tax withholding obligations in connection with vesting of previously awarded shares of restricted stock.

Restricted stock scheduled to vest in three substantially equal annual installments on each of the first business days of September 2026, 2027 and 2028.

Options scheduled to vest and become exercisable in three equal annual installments on each of the first business days of September 2026, 2027 and 2028.

Options scheduled to vest and become exercisable in three substantially equal annual installments on each of the first business days of September 2026, 2027 and 2028.

Reflects the weighted average price of 50,751 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $27.00 to $27.89 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 11,990 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 21, 2025 with sale prices ranging from $27.80 to $28.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by Summers Value Fund LP ("Summers Value Fund"). Mr. Summers, as the Managing Member of each of Summers Value Partners GP LLC, the general partner of Summers ValueFund, and Summers Value Partners LLC ("Summers Value Partners"), the investment manager of Summers Value Fund, may be deemed to beneficially own the securities owned directly by Summers ValueFund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 11,990 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 21, 2025 with sale prices ranging from $27.80 to $28.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 735 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 21, 2025 with sale prices ranging from $28.81 to $29.06 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 734 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 21, 2025 with sale prices ranging from $28.81 to $29.06 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by Summers Value Fund LP ("Summers Value Fund"). Mr. Summers, as the Managing Member of each of Summers Value Partners GP LLC, the general partner of Summers ValueFund, and Summers Value Partners LLC ("Summers Value Partners"), the investment manager of Summers Value Fund, may be deemed to beneficially own the securities owned directly by Summers ValueFund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 1,947 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 20, 2025 with sale prices ranging from $29.51 to $30.075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by Summers Value Fund LP ("Summers Value Fund"). Mr. Summers, as the Managing Member of each of Summers Value Partners GP LLC, the general partner of Summers ValueFund, and Summers Value Partners LLC ("Summers Value Partners"), the investment manager of Summers Value Fund, may be deemed to beneficially own the securities owned directly by Summers ValueFund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 15,689 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 20, 2025 with sale prices ranging from $28.50 to $29.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by Summers Value Fund LP ("Summers Value Fund"). Mr. Summers, as the Managing Member of each of Summers Value Partners GP LLC, the general partner of Summers ValueFund, and Summers Value Partners LLC ("Summers Value Partners"), the investment manager of Summers Value Fund, may be deemed to beneficially own the securities owned directly by Summers ValueFund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 15,689 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 20, 2025 with sale prices ranging from $28.50 to $29.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the weighted average price of 1,947 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 20, 2025 with sale prices ranging from $29.51 to $30.075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

All sales of shares reported are part of a diversification of a portion of the reporting person's securities portfolio and individual financial and retirement planning.

Reflects the weighted average price of 38,954 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 18, 2025 with sale prices ranging from $29.14 to $29.83 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

All sales of shares reported are part of a diversification of a portion of the reporting person's securities portfolio and individual financial and retirement planning.

All sales of shares reported are part of a diversification of a portion of the reporting person's securities portfolio and individual financial and retirement planning.

Reflects the weighted average price of 7,558 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 14, 2025 with sale prices ranging from $31.70 to $32.59 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

All sales of shares reported are part of a diversification of a portion of the reporting person's securities portfolio and individual financial and retirement planning.

Reflects the weighted average price of 1,082 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on February 14, 2025 with sale prices ranging from $33.04 to $33.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.